Published
Video length: 2 min
Health: Doliprane will join an American investment fund
Health: Doliprane will join an American investment fund
(Franceinfo)
Friday October 11, the pharmaceutical company Sanofi announced negotiations with an American investment fund in order to give it control of its subsidiary.
The little yellow box passes under the American flag. After more than fifty years in the fold of the French pharmaceutical laboratory Sanofi, the Doliprane will join the American investment fund CD&R. The French pharmaceutical group has confirmed that it is in exclusive negotiations to sell it a majority stake in Opella. This is the entity that markets the very popular paracetamol brand Doliprane.
This split raises concerns in France regarding the future of Doliprane, manufactured in Lisieux (Calvados) and Compiègne (Oise) and the risks of relocation of its production. Sanofi’s announcement seems to contradict Emmanuel Macron’s stated desire to “relocalize” the production of certain drugs in France.
Watch the full report in the video above